AI assistant
Sending…
Immunovant, Inc. — Director's Dealing 2021
Aug 16, 2021
31436_dirs_2021-08-16_c29bce0b-646c-4b91-8bfc-22d5430caa2c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immunovant, Inc. (IMVT)
CIK: 0001764013
Period of Report: 2021-08-13
Reporting Person: Pande Atul (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-13 | Common Stock | P | 5000 | $7.98 | Acquired | 45200 | Indirect |
More from Immunovant, Inc.
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 27
Earnings Release
2026
Feb 6
Interim / Quarterly Report
2026
Feb 6
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 9
Director's Dealing
2025
Dec 19
Capital/Financing Update
2025
Dec 12